News headlines about St Jude Medical (NYSE:STJ) have been trending positive on Saturday, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a media sentiment score of 0.26 on Accern’s scale. Accern also gave news coverage about the medical technology company an impact score of 47.0517782357178 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

NYSE STJ remained flat at $$80.82 on Friday. St Jude Medical has a fifty-two week low of $48.83 and a fifty-two week high of $84.00. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.31 and a current ratio of 1.93.

About St Jude Medical

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Featured Story: NASDAQ Stock Market Explained

Insider Buying and Selling by Quarter for St Jude Medical (NYSE:STJ)

Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with's FREE daily email newsletter.